Showing 375 results

Filters Content type: News, Editors' picks, About HIV Topic: Drug-resistant TB

Some strains of tuberculosis (TB) are resistant to several different drugs. Multidrug-resistant TB (MDR-TB) can usually be treated successfully after identifying which drugs the bacteria are still susceptible to. A strain of TB that is resistant to a larger number of drugs is known as extensively drug-resistant TB (XDR-TB).

TB treatment

WHO launches updated guidance on HIV-associated TB

Editor's pick
World Health Organization
24 May 2024
Drug-resistant TB

Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options

Editor's pick
Unitaid
15 November 2023
Access to healthcare

Activism delivers unprecedented victories in TB testing and treatment access

Editor's pick
Treatment Action Group
10 November 2023
Access to healthcare

TAG Reacts to J&J Commitment to Not Enforce Patents on Bedaquiline

Editor's pick
Treatment Action Group
3 October 2023
Drug-resistant TB

Johnson & Johnson drops secondary patents for bedaquiline

Editor's pick
CIDRAP
3 October 2023
TB epidemiology

Very poor long-term outcomes for people with TB and HIV in Eastern Europe

News
29 September 2023
Access to healthcare

Major drug company bends in battle over access to key TB treatment

Editor's pick
Science
18 July 2023
Access to healthcare

MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug

Editor's pick
MSF
24 March 2023
TB treatment

India: With daily injections and two years of costly treatment, TB survivors look for a ray of light

Editor's pick
Indian Express
16 January 2023
Drug-resistant TB

Groundbreaking MSF trial finds better treatment for people with drug-resistant tuberculosis

Editor's pick
MSF
21 December 2022
Drug-resistant TB

WHO announces landmark changes in treatment of drug-resistant tuberculosis

Editor's pick
World Health Organization
19 December 2022
TB treatment

Response to TB treatment trials results published and presented during the 2022 Union World Conference on Lung Health

Editor's pick
TAG
22 November 2022
Drug-resistant TB

Shorter Treatment Regimen for Drug-Resistant TB is More Effective

Editor's pick
Health Policy Watch
9 November 2022
TB treatment

A Breakthrough Tuberculosis Treatment Just Got Safer

Editor's pick
Health Policy Watch
2 September 2022
Drug-resistant TB

Oral six-month treatment for MDR-TB is safe and effective in people with HIV

News
2 August 2022
Drug-resistant TB

Treatment Success Likely for Multidrug-Resistant Tuberculosis During Pregnancy

Editor's pick
Infectious Disease Advisor
21 July 2022
Drug-resistant TB

Shorter, simpler DR-TB regimen expected later this year

Editor's pick
Spotlight
22 June 2022
Drug-resistant TB

Rapid communication: Key changes to the treatment of drug-resistant tuberculosis

Editor's pick
World Health Organization
4 May 2022
Access to healthcare

Ukraine’s ‘Model’ TB Programme Destroyed by War, as Global TB Response Faces ‘Disastrous’ Funds Shortfall

Editor's pick
Health Policy Watch
23 March 2022
Drug-resistant TB

Fewer Pills Plus Shorter Time: New Way to Control Drug-Resistant TB?

Editor's pick
MedPage Today
21 February 2022
Drug-resistant TB

EXCELLENT NEWS: MSF TB-PRACTECAL clinical trial finds short, effective and safe drug-resistant tuberculosis treatment

Editor's pick
MSF
20 October 2021
Drug-resistant TB

TB in Persons with HIV in South Africa Increasingly Rifampicin-Resistant

Editor's pick
Contagion Live
31 August 2021
Drug-resistant TB

Shorter, less toxic treatment for highly drug-resistant TB cures nine out of ten

News
21 July 2021
Drug-resistant TB

US: Prevalence of transmitted resistance to common HIV drugs remains stable

Editor's pick
Healio
21 July 2021